A new partnership aims to provide liquidity to healthcare investors

Leerink Capital Partners recently raised a new $192 million fund along with Revelation Partners to invest in direct secondaries in healthcare companies. Scott Halsted, managing director at Revelation, explains the strategy and the current environment for healthcare secondaries investments.

To view this content you must sign in:

Not yet registered? Join today to access Secondaries Investor's industry insights and updates.